Biotech and drug-innovation themes continue to dominate markets—from AI-driven drug discovery to blockbuster obesity treatments—and a new ETF filing suggests asset managers want a piece of that ...

In a smaller yet noteworthy trade, ARK purchased 25,000 shares of the 3iQ Solana Staking ETF (SOLQ), with a total value of $173,042. This acquisition reflects ARK’s interest in the growing ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Launched on December 20, 2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Cathie Wood’s ARK ETF published their daily trades for Tuesday, March 3rd, 2026, showcasing a mix of significant buying and selling activity across various sectors. The standout transaction was the ...

Sold 24,270 shares of IBB; estimated trade value of $3.50 million based on quarterly average pricing. Net position value decreased by $3.50 million. Represents a 3.27% shift in 13F reportable assets ...

iShares Biotechnology ETF earns a reiterated hold rating as it consolidates near all-time highs with balanced risk/reward. IBB’s valuation is fair at a 19x P/E and low 3% EPS growth, resulting in an ...

For investors seeking momentum, State Street SPDR S&P Biotech ETF XBI is probably on the radar. The fund just hit a 52-week high and has risen 98.15% from its 52-week low price of $66.66/share. But ...

The Dow Industrials fell about 785 points Thursday as oil prices surged amid the U.S.-Iran war. The 30-stock index is on ...

Shares of biotech companies were outpacing the broader market on Thursday. The State Street SPDR S&P Biotech ETF was up 2.7%, compared with the 0.8% gain of the S&P 500. A significant portion of these ...